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The small intestinal epithelium is the most rapidly
self-renewing tissue of mammals. Proliferative cells
are confined to crypts, while differentiated cell types
predominantly occupy the villi. We recently demon-
strated the existence of a long-lived pool of cycling
stem cells defined by Lgr5 expression and inter-
mingled with post-mitotic Paneth cells at crypt
bottoms. We have now determined a gene signature
for these Lgr5 stem cells. One of the genes within this
stem cell signature is the Wnt target Achaete scute-
like 2 (Ascl2). Transgenic expression of the Ascl2
transcription factor throughout the intestinal epithe-
lium induces crypt hyperplasia and ectopic crypts
on villi. Induced deletion of the Ascl2 gene in adult
small intestine leads to disappearance of the Lgr5
stem cells within days. The combined results from
these gain- and loss-of-function experiments imply
that Ascl2 controls intestinal stem cell fate.
INTRODUCTION
Intestinal crypts contain stem cells and their transit-amplifying
(TA) daughter cells. Cells exiting the proliferative crypts onto
the villi terminally differentiate into enterocytes, goblet cells
and enteroendocrine cells. Paneth cells escape the crypt-villus
flow by migrating to crypt bottoms where they live for several
weeks. With the exception of stem cells and Paneth cells, the
intestinal epithelium is renewed approximately every 5 days
(Barker et al., 2008). Proliferation of epithelial crypt cells is
Wnt-dependent. Mice that are mutant for an intestine-specific
member of the Tcf transcription factor family, Tcf4/Tcf7l2, fail
to establish proliferative crypts during late gestation (Korinek
et al., 1998), while conditional deletion of b-catenin (Ireland
et al., 2004; Fevr et al., 2007) as well as transgenic expression
of the secreted Dickkopf-1 Wnt inhibitor (Pinto et al., 2003; Kuh-
nert et al., 2004) leads to disappearance of proliferative crypts in
adult mice. Moreover, malignant transformation of intestinal
epithelium is almost invariably initiated by activating Wnt
pathway mutations (Korinek et al., 1997; Morin et al., 1997).
Because of the intimate connection between Wnt signaling
and intestinal biology, we have attempted to unravel the TCF4target gene program activated by this pathway in crypts and
colorectal tumors (van de Wetering et al., 2002; van Es et al.,
2005; van der Flier et al., 2007). Using Cre-mediated genetic
tracing,wedemonstrated that Lgr5marks long-lived,multipotent
stem cells (Barker et al., 2007), as predicted originally by Leblond
and colleagues (Cheng and Leblond, 1974a, 1974b; Bjerknes
and Cheng, 1981a, 1981b, 1999). Each crypt bottom harbours
around six of these small, cycling cells intermingled with Paneth
cells. Although Lgr5 stem cells occasionally occupy a position
directly above the Paneth cells, they are distinct from another
proposed stem cell population located at the so called +4 posi-
tion (Potten et al., 1974, 1977), since Lgr5 stem cells are not
particularly radiation-sensitive and do not retain DNA labels
(Barker et al., 2007, 2008). Bmi1 expression reportedly also
marks cells at position +4. Lineage tracing has revealed that
Bmi1+ cells mark pluripotent stem cells that replenish the epithe-
liumwith similar kinetics to Lgr5 stemcells (Sangiorgi andCapec-
chi, 2008). Bmi1 and Lgr5 stem cells may be distinct or may
represent overlapping or even identical stem cell populations.
Here, we identify theAscl2 gene as one of a few Lgr5 stem cell-
enriched genes that were not detected in the immediate daugh-
ters. Ascl2 (Mash2/HASH2) is homologous to the Drosophila
Achaete-scute complex genes (Johnson et al., 1990). Ascl2
expression in the intestinal epithelium is Wnt-dependent (San-
som et al., 2004; Jubb et al., 2006; van der Flier et al., 2007).
The Ascl2 gene encodes a basic helix-loop-helix (bHLH) tran-
scription factor with an unusually restricted expression pattern,
i.e. its expression is predominantly detected in extraembryonic
tissues (Guillemot et al., 1994) and in intestinal epithelium (see
below). Ascl2/ embryos die from placental failure around
10.5 days post-coitum, when the spongiotrophoblasts lineage
is depleted and the number of giant cells is elevated (Guillemot
et al., 1994). Here we demonstrate an essential role for Ascl2 in
the maintenance of adult intestinal stem cells.
RESULTS
Intestinal Stem Cell Transcriptome
We sorted GFP-positive epithelial cells from isolated crypts of
Lgr5-EGFP-ires-CreERT2 mice (see Experimental Procedures).
FACS analysis distinguished a GFP-high (GFPhi) and a GFP-
low (GFPlo) population (Figure 1A), whichwe tentatively identified
as Lgr5 stem cells and their immediate transit-amplifying daugh-
ters, respectively. A single mouse intestine routinely yieldedCell 136, 903–912, March 6, 2009 ª2009 Elsevier Inc. 903
several hundred thousand GFPhi and GFPlo cells. mRNA
samples were subjected to comparative gene expression
profiling. A comprehensive list of Lgr5 stem cell genes is given
in Table S1 (available with this article online). The gene that
was most highly enriched in the GFPhi cells was, satisfactorily,
the Lgr5 gene itself. Multiple genes on the list were already iden-
tified as intestinalWnt target genes previously (van der Flier et al.,
2007) (Table S1). While in situ hybridizations on these Wnt target
genes typically confirmed high level expression in Lgr5 stem
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Figure 1. Ascl2, Olfm4, and Lgr5 as Intestinal Stem
Cell Markers
(A) Confocal images of an isolated Lgr5-EGFP-ires-CreERT2
crypt (left). After treatment with trypsine, GFPhi and GFPlo cells
were identifiable upon sorting (right/middle) when compared
to wild-type crypt cells (right/top). Confocal image of healthy
sorted GFPhi cells (right/bottom).
(B) Sox9 antibody staining shows high level expression in Lgr5
stem cells and Paneth cells. TA cells directly above the Paneth
cells also express the gene, albeit at a much lower level.
(C) In situ hybridization for Ascl2 reveals an Lgr5 stem cell-
restricted expression pattern.
(D) In situ hybridization for Olfm4 reveals an Lgr5 stem cell-
restricted expression pattern.
(E) Monoclonal Ascl2 antibody stains nuclei of Lgr5 stem cells
(arrows). Neither the surrounding post-mitotic Paneth cells at
the crypt base, nor the TA cells show any positive signal.
Hematoxylin is used as a counter stain to visualize Paneth
cell granules.
(F) Cytoplasmic GFP staining in Lgr5-EGFP-ires-CreERT2
knock-in mice reveals Lgr5 stem cells (arrows). Hematoxylin
is used as a counter stain.
Scale bars represent 20 mm.
cells, TA cells directly above the Paneth cells often
also expressed these genes, albeit at a lower level.
As an example, Figure 1B shows the expression of
Sox9, a Wnt-responsive gene (Blache et al., 2004)
crucial for Paneth cell specification (Bastide et al.,
2007; Mori-Akiyama et al., 2007).
Ascl2 was one of the known Wnt target genes
(Sansom et al., 2004; Jubb et al., 2006; van der Flier
et al., 2007) and was expressed in adenomas as
expected (Figures S1A, S1D, and S1E). Its physio-
logical expression, however, was restricted to cells
at the base of crypts as revealed by in situ hybridiza-
tion (Figure 1C). In situ hybridization analysis also
identified Olfactomedin-4 (Olfm4) as a highly-
specific and robust marker for Lgr5 stem cells
(Figure 1D). Olfm4 was not expressed under the
control of Wnt, since it was absent from adenomas
(Figure S1B). Human OLFM4 is enriched in human
colon crypts (Kosinski et al., 2007). OLFM4 is
a secreted molecule originally cloned from human
myeloblasts (Zhang et al., 2002). Recently, it was
shown thatXenopusONT1, anOlfm familymember,
acts as a BMP antagonist (Inomata et al., 2008).
To study the expression pattern of Ascl2 more
precisely we generated monoclonal antibodies
against the C-terminal part of the mouse Ascl2 protein. The
mouse Ascl2 protein was detected in E10.5 spongiotrophoblasts
cell nuclei by immunohistochemistry (IHC) (Figure S1C). In the
intestine, Ascl2 was found to be expressed in slender cells
with the unique morphology and location of Lgr5 stem cells
(Figure 1E), yet was not expressed in Paneth cells or the
transit-amplifying cells. Figure 1F compares Ascl2 nuclear
staining to cytoplasmic GFP in Lgr5-EGFP-ires-CreERT2
knock-in intestine. Ascl2 was expressed by the Lgr5 stem cells904 Cell 136, 903–912, March 6, 2009 ª2009 Elsevier Inc.
at the crypt base as revealed by serial sectioning (Figures S1F
and S1G).
GFPhi and GFPlo cells from duodenum, ileum and colon of
Lgr5-EGFP-ires-CreERT2 mice were subjected to real-time
qPCR analysis. This confirmed that Lgr5, Ascl2, Tnfrsf19 and
Olfm4 were highly enriched in stem cells of the small intestine
(Figure S1H). Only Lgr5 and Ascl2 were enriched in the GFPhi
stem cells of the colon. Expression of Bmi1, another putative
stem cell marker, was readily detected in all fractions and was
slightly enriched in GFPhi stem cells of the small intestine, albeit
to a lesser extent than Lgr5 or Ascl2. We then tested intestines
from 4 week-old Bmi1 null animals (van der Lugt et al., 1994) for
stem cell marker gene expression. Histologically and by marker
analysis, the intestinal epitheliumof thesemutantmicewas indis-
tinguishable from wild-type littermates (van Lohuizen and
Clevers, unpublished). Both, Ascl2 and Olfm4 were expressed
in the intestines of these animals (Figures S1I and S1J).
Consultation of adult man and mouse EST data sets using the
Unigene database (http://www.ncbi.nlm.nih.gov/sites/entrez?
db=unigene&cmd=search&term=) indicated that Ascl2 is ex-
pressed uniquely in the small intestine and colon.
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Figure 2. Intestine-Specific Ascl2 Misexpression
(A) Monoclonal Ascl2 antibody staining reveals Lgr5 stem cell-
restricted Ascl2 expression in wild-type animals.
(B) In villin-Ascl2-transgenic animals, epithelial nuclei along the
crypt-villus axis stain for Ascl2. Insert outlines the transgene
construct.
(C) H&E staining showing normal crypt-villusmorphology in the
duodenum of wild-type animals.
(D) H&E staining showing aberrant epithelium morphology in
the duodenum of transgenic animals. Villi are branched and
display crypt-like pockets (arrows).
(E) H&E staining showing normal crypt-villus morphology in the
ileum of wild-type animals.
(F) H&E staining showing elongated crypts (arrow), with short,
disorganized villi in the ileal epithelium of Ascl2 transgenics.
Scale bars represent 50 mm.
Transgenic Expression of Ascl2
We generated transgenic mice expressing a mouse
Ascl2 cDNA under the control of the villin promoter
(insert in Figure 2B). This promoter drives expres-
sion throughout the intestinal epithelium and
becomes fully active during late gestation (Pinto
et al., 1999). Four independent transgenic mice
were born. Three of these showed growth retarda-
tion and were sacrificed within 2-3 weeks postna-
tally. The founder of the fourth line was healthy and
fertile, yet yielded multiple litters which contained
transgenic F1 offspring at Mendelian ratios. These
transgenic F1 individuals displayed the same
phenotype as the three other independent trans-
genic mice. This fortunate situation allowed us to
study the phenotype of the fourth transgenic line
and to confirm the observations using fixedmaterial
from the three independent transgenic mice.
Transgenic animals were analyzed at P14 when
they were still relatively healthy, yet had already re-
placed their postnatal intervillus pockets by adult-type crypts
(Gregorieff and Clevers, 2005). Nuclear Ascl2 was observed
throughout crypt and villus epithelium (Figures 2A and 2B).
H&E histology revealed dramatic changes in the transgenic
epithelium. In the duodenum, villi were branched and displayed
crypt-like pockets (Figures 2C and 2D). In the ileum, crypts
were elongated (‘‘hyperplastic’’), while villi were short and disor-
ganized (Figures 2E and 2F). Ki67 staining revealed that prolifer-
ation in the Ascl2 transgenic intestines occurred in pockets along
the villi (Figures 3A and 3B) which also expressed the Wnt target
gene cMyc (Figures 3E and 3F). Ets2, a Wnt target gene specif-
ically expressed at the crypt base (van de Wetering et al., 2002)
and enriched in Lgr5 stem cells (Table S1) was strongly ex-
pressed in the elongated crypts and villi (Figures 3I and 3J).
The expression domains of the Olfm4 and Lgr5 genes were
expanded in the hyperplastic ileal crypts (Figures 3C, 3D, 3G,
and 3H), aswas the expression domain of theSox9 gene (Figures
3K and 3L).
In the fly, the achaete-scute gene products form heterodimers
with the Daugtherless protein (Cabrera and Alonso, 1991; Caudy
et al., 1988). In a yeast 2-hybrid assay using ASCL2 as bait onCell 136, 903–912, March 6, 2009 ª2009 Elsevier Inc. 905
a human colon library, we predominantly found the nuclear
proteins E22, E2A and HEB as ASCL2-binding partners confirm-
ing previous observations (Johnson et al., 1992; Scott et al.,
2000). These three common E-proteins are the homologs of
Daughterless. E2a and Heb were expressed in crypts and
adenomas (Figures S2A and S2B). The crypt-restricted expres-
sion of these co-factors explained why the transgenic overex-
pression of Ascl2 only partially affected the villus epithelium.
Generation of a Conditional Ascl2 Allele
As Ascl2/ animals die around E10.5 (Guillemot et al., 1994), we
generated a conditional Ascl2 allele (Figure S3A). The murine
Ascl2 gene contains three exons of which the middle exon
encodes the protein. We introduced LoxP sites into 50 UTR of
exon I and in intron II. Cre-mediated recombination should result
in a null allele. The paternal Ascl2 allele is silenced during post-
implantation development (Guillemot et al., 1995). By utilizing
the LoxP site in exon I as an allele-specific marker, we found
that both alleles of Ascl2 were expressed in the mouse intestine
(Figure S3B). We crossed the floxed animals with the Ah-Cre
mouse (Ireland et al., 2004) in which expression of Cre is driven
by the Cyp1a promoter, inducible in a number of tissues by
b-Naphtoflavone (ßNF). The resulting gene deletion in the intes-
tinal epithelium is highly efficient, includes the intestinal stem
cells and remains stable over many months (Ireland et al.,
Figure 3. Marker Analysis in the Villin-Ascl2
Intestine
Marker analysis of intestinal epithelium inwild-type
(A, C, E, G, I, and K) and Ascl2-transgenic (B, D, F,
H, J, and L) animals.
(A and B) Ki67 analysis shows aberrant (arrow),
dividing regions along the villus epithelium of
Ascl2 transgenic animals.
(C and D) In situ hybridization for the Lgr5 stem cell
markerOlfm4 shows increased signal in the hyper-
plastic ileal crypts of Ascl2 transgenics.
(E and F) The aberrant dividing regions along the
villus epithelium ofAscl2 transgenics are also posi-
tive for the crypt marker cMyc (arrow).
(G and H) In situ hybridization for stem cell marker
Lgr5 shows elevated expression in the hyper-
plastic ileal crypts.
(I and J) In situ hybridization for the crypt marker
Ets2 show that the expression in Ascl2 transgenic
animals is found along the entire crypt-villus axis.
(K and L) IHC Staining for the crypt marker Sox9
shows expanded expression of this protein in the
hyperplastic crypts of Ascl2 transgenic animals.
Scale bars represent 50 mm.
2004). A dramatically different observa-
tion wasmade when we deleted the func-
tionally important c-Myc gene using the
same protocol (Muncan et al., 2006).
The epithelium, which was essentially c-
Myc/ at day 4 post-induction (PI), was
entirely replaced by wild-type epithelium
derived from low numbers of escaping,
nondeleted cells within 2-3 weeks.
We analyzed adult Ah-Cre/Ascl2floxed/floxed animals at 5, 8,
11 and 15 days PI and compared these to ßNF-treated
Ascl2floxed/floxed litter mates. Intestinal epithelium was subjected
to Southern blot analysis (Figure S3A). Figure 4A (upper panel)
shows recombination of the Ascl2floxed/floxed locus at the indi-
cated days PI. Complete recombination was observed at the 5-
and8-day timepoints. At 11daysPI, a partial return of nonrecom-
bined alleles was observed. At day 15, recombined alleles were
no longer observed. The rapid reappearance of wild-type epithe-
lium implied a strong selective pressure favoring the few remain-
ingAscl2+ epithelial Lgr5 stemcells. TheAh-Cre transgene is also
inducible in the liver, albeit to a lesser extent (Ireland et al., 2004).
As the Ascl2 gene is not expressed in liver, its deletion should be
neutral in terms of selection. A significant, albeit not entirely
complete, deletion of the Ascl2 gene was observed in liver
(Figure 4A, lower panel). This deletion pattern remained
unchangedover time.Quantitative recombinationwasconfirmed
through Northern blot analysis of intestinal epithelial extracts
(Figure 4B) and Ascl2 antibody stainings (Figures 4C–4G).
To directly visualize the rescue process, we bred the Cre-
activatableRosa26-LacZ reporter (Soriano,1999) into theAh-Cre/
Ascl2floxed/floxed strain.Rosa26-LacZ/Ah-Cre/Ascl2floxed/floxedani-
mals were treated with ßNF and intestines were isolated at 5, 10
or 20 days PI. Intestines of Rosa26-LacZ/Ah-Cre/Ascl2floxed/wt
animals were used as controls. Figures 4H–4K illustrates LacZ906 Cell 136, 903–912, March 6, 2009 ª2009 Elsevier Inc.
staining of the duodenum. At 5 days PI, virtually all cells were re-
combined and blue except for long-livedPaneth cells (Figure 4H).
At 10 daysPI, nonrecombined epithelial cells started reappearing
(Figure 4I). At 20 days PI, virtually all crypts were again wild-type
(Figure 4J). In heterozygous intestines at 20 days PI, the entire
epithelium stained blue (Figure 4K).
Intestinal Stem Cells Are Lost upon Conditional
Deletion of Ascl2
No dramatic histological differences were observed by H&E
staining (Figures 5A and 5B) or Ki67 staining (Figures 5C and
5D) at 5 days PI. The crypt base entirely consisted of Paneth
cells, while Lgr5 stem cells recognizable by their elongated
Ki67+ nuclei were conspicuously absent (Figures 5C and 5D).
These observations were confirmed by electron microscopy
(Figures S4A and S4B). There was an increase in apopototic cells
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3.4 kb, floxed allele
2.2 kb, floxed recomb. allele
Time course 
4.9 kb, wt allele
3.4 kb, floxed allele
2.2 kb, floxed recomb. allele
Intestine
Liver
Ascl2 flox:  +/+        +/+      +/+        +/+        +/+ 
Ah-Cre:    -            +         +           +           +
          days PI:    5           5         8          11          15
Control Time course 
Ascl2
18S
C Control 5 days PI 8 days PI 11 days PI 15 days PIE F G
H I
J K
Control
5 days PI 10 days PI
20 days PI
Figure 4. Conditional Ascl2 Inactivation in
the Intestinal Epithelium
(A) Southern blot analysis of genomic DNA of intes-
tinal epithelial cell extracts (upper panel) and liver
samples (lower panel) of Ah-Cre/Ascl2floxed/floxed
animals 5, 8, 11, and 15 days PI and control
animals. DNA was digested with EcoRV and
hybridized with probe A (as indicated in
Figure S3A).
(B) Ascl2 Northern blot analysis on total RNA from
intestinal epithelial cell extracts of Ah-Cre/
Ascl2floxed/floxed animals 5, 8, 11, and 15 days PI
and control.
(C–G) Monoclonal Ascl2 antibody staining demon-
strates Lgr5 stem cell restricted expression of the
Ascl2 protein (arrows) in control animals (C). 5 (D)
and 8 (E) days PI the Ascl2 signal is completely
gone. The signal reappears in the Lgr5 stem cells
11 (F) and 15 (G) days PI.
(H–K) LacZ staining of the duodenum illustrates
recombination efficiency in Rosa26-LacZ/Ah-Cre/
Ascl2floxed/floxed animals 5, 10 and 20 days PI. At
5 days PI, virtually all cells were recombined
(blue) except for long-lived Paneth cells (H). At 10
days PI, nonrecombined epithelial cells started re-
appearing (I). At 20 days PI, virtually all crypts
were wild-type (J). In Rosa26-LacZ/Ah-Cre/
Ascl2floxed/wt control animals 20 days PI, the entire
intestinal epithelium remained blue (K).
Scale bars represent 25 mm.
in the crypts of floxed animals (Figures 5E
and 5F). Analysis at late time points PI re-
vealed a strong increase in crypt fission
profiles (Figures 5G and 5H). Crypt fission
represents a powerful repair mechanism
of the intestinal epithelium, for instance
after radiation injury or genetic damage
(Cairnie and Millen, 1975; Muncan et al.,
2006).
To follow the fate of Lgr5 stem cells
more precisely, we utilized the robust
Olfm4 marker. In situ hybridizations for
Olfm4 expression confirmed that the Olfm4+ Lgr5 stem cells
were present in every single crypt of control intestines
(Figure 6A). Five days PI, Olfm4+ Lgr5 stem cells had vanished
(Figure 6B). At day 8 PI, anOlfm4 signal reappeared in occasional
crypts (Figure 6C). By 11 days PI (Figure 6D), larger patches of
Olfm4+ crypts reappeared. By day 15 PI, all crypts were Olfm4+
(Figure 6E).
To investigate the target gene program regulated by Ascl2 in
the small intestine, we performed comparative gene expression
profiling on RNA samples from isolated intestinal epithelium
of Ah-Cre/Ascl2floxed/floxed animals and Ah-Cre/Ascl2floxed/wt
control animals at day 3 and 5 days PI. A total of 130 genes,
also expressed by Lgr5 stem cells, was significantly downregu-
lated > 1.5-fold at both time points PI. Comparison of these Ascl2
target genes with the stem cell gene signature (Table S1)
revealed a 25% overlap (Figure 7A; Table S2).Cell 136, 903–912, March 6, 2009 ª2009 Elsevier Inc. 907
To identify in vivo ASCL2 binding sites, we performed chro-
matin immunoprecipitations (ChIP) on human LS174T colorectal
cancer (CRC) cells. We probed a customized array containing
a set of TCF4-regulated genes (Hatzis and Clevers, unpub-
lished). Potential ASCL2-bound regulatory regions were verified
by qPCR. LGR5, EPHB3 and TNFRSF19 promoters were bound
by ASCL2, while the OLFM4 promoter was not. Nonpromoter
sequences in the PTPRO, SOAT1, ETS2 and SOX9 loci were
also bound by ASCL2 (Figure 7B).
As a further validation of these data, we created an LS174T
transfectant carrying a stably integrated, doxycycline-inducible
sh-RNA expression vector targeting ASCL2. An essentially
complete knock-down of the ASCL2 mRNA occurred within
24 hr upon RNAi induction, as shown by Northern blot analysis
(Figure S5A). We used this cell line to validate the generated
ChIP signals. As can be seen in Figure S5B, the ChIP signals for
the EPHB3 promoter and the ETS2 enhancer disappeared upon
ASCL2 knock-down. We cloned the putative SOX9 enhancer in
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Caspase-3 Caspase-3
Control animals: Ascl2
floxed/floxed
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floxed/floxed
Increase in crypt fissionNormal crypts
Figure 5. Expansion of Ascl2 Wild-Type Crypts
through Crypt Fission
(A and B) H&E staining reveals normal morphology of crypt-
villus epithelium of Ascl2floxed/floxed control animals (A) and
Ah-Cre/Ascl2floxed/floxed animals 5 days PI (B).
(C and D) Ki67 staining showing normal numbers of prolifer-
ating cells in intestinal crypts of Ascl2floxed/floxed control
animals (C) and Ah-Cre/Ascl2floxed/floxed animals 5 days PI (D).
(E and F) Active Caspase-3 staining showing apoptosis
predominantly at the villus tip in Ascl2floxed/floxed control
animals (E). At 5 days PI, a strong increase in apoptosis in
the crypt region of Ah-Cre/Ascl2floxed/floxed animals can be
observed (F).
(G and H) Ki67 staining showing at a low magnification, normal
crypt-villus epithelium in Ascl2floxed/floxed control animals (G).
An increase in crypt fission (arrows) in Ah-Cre/Ascl2floxed/floxed
animals 11 days PI is observed (H).
Scale bars represent 50 mm.
a luciferase reporter plasmid. Transient transfection
was performed in the inducible LS174T ASCL2
RNAi cell line. Figure 7Cshows that the spontaneous
activity of the SOX9 enhancer was significantly
downregulated upon ASCL2 knock-down. For the
reverse experiment, we stably integrated a dox-
inducible ASCL2 expression plasmid into HCT116
cells. This CRC cell line does not express endoge-
nous ASCL2 (Figure S5C). Transient transfection of
the SOX9 enhancer plasmid in this cell line resulted
in a significant activation of the SOX9 enhancer
upon ASCL2 induction (Figure 7D).
We interpreted the combined observations in the
following manner. The Ascl2 gene is crucial for the
maintenance of Lgr5 stem cells, the only cells in
the intestine that express the gene. Part of the
stemcell signature is Ascl2-dependent and involves
binding of Ascl2 to promoters and/or enhancers
elements to activate transcription of these target
genes. In the absence of Ascl2 expression, Lgr5
stem cells rapidly disappear. Ascl2 deletion in TA
cells does not directly harm these cells as they normally don’t
express the gene. The mutant TA cells continue to proliferate
and provide the villi with differentiated cells. However, no new
TA cells are produced from Lgr5 stem cells in mutant crypts.
The strong increase in apoptosis in the TA compartment likely
mirrors the limited self-renewal capacity that these cells possess.
As a consequence, a strong selective pressure is exerted which
favors the re-emergence of ‘‘escaper’’ crypts harboring intact
Ascl2 alleles.
DISCUSSION
Here, we define a minimal gene expression profile for the Lgr5
stem cells. Lgr5 is the most differentially expressed gene within
this set. Many other genes in the signature represent previously
identified Wnt-dependent genes, e.g., Ascl2, CD44, Ephb3 and
Sox9 (van der Flier et al., 2007). Given the intimate connection
between Wnt signaling and the biology of stem cells (Reya and908 Cell 136, 903–912, March 6, 2009 ª2009 Elsevier Inc.
Clevers, 2005), this was not surprising. At least one novel marker
for Lgr5 stem cells, Olfm4, was not expressed under the control
of the Wnt pathway, implying the existence of a Wnt-indepen-
dent specifier for stem cell identity.
Ascl2 is one of the mammalian homologous of the Drosophila
achaete-scute complex genes (Johnson et al., 1990). This
complex encodes related bHLH proteins that are powerful regu-
lators of cell fate. The achaete-scute genes are initially
expressed in proneural cell clusters were they promote neuro-
blast differentiation. They are essential for the differentiation of
A B
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8 days PI
11 days PI 15 days PI
Figure 6. Intestinal Stem Cells Are Lost upon Ascl2 Deletion
Olfm4 in situ hybridizations to visualize Lgr5 stem cells in Ah-Cre/
Ascl2floxed/floxed small intestines 5, 8, 11 and 15 days PI and in a control intestine.
(A) Olfm4 in situ staining at low magnification shows Lgr5 stem cell specific
staining in Ascl2floxed/floxed control animals in every crypt.
(B) The Olfm4 signal is almost completely gone 5 days PI in Ah-Cre/
Ascl2floxed/floxed animals. Sporadic positive Lgr5 stem cells can be observed
(arrow).
(C) Eight days PI most of the crypts are still negative for Olfm4, although
sporadic crypts display normal staining, while other crypts contain 1 or 2
positive Lgr5 stem cells (arrow).
(D) At 11 days PI, the tissue of Ah-Cre/Ascl2floxed/floxed shows patches of
positive and patches of negative crypts for Olfm4.
(E) The Olfm4 signal is completely restored 15 days PI in the Ah-Cre/
Ascl2floxed/floxed animals.
Scale bars represent 50 mm.the central as well as peripheral nervous system (Calleja et al.,
2002). Achaete-scute genes are best known as targets of the
Notch pathway. Hairy/Enhancer of Split genes, activated by
Notch signaling, directly repress the proneural achaete-scute
genes. The indirect repression by Notch signals allows
achaete-scute gene-expressing cells to be singled-out through
lateral inhibition (Simpson, 1990). However, achaete-scute
genes can also be expressed under control of the Wnt pathway.
Wingless expression is required for achaete-scute complex gene
expression along the wing margin and for achaete-scute-depen-
dent formation of margin bristles and their precursors (Phillips
and Whittle, 1993). Intestinal Ascl2 is expressed under the
control of the Wnt pathway. In a recent genome-wide TCF4
Chromatin Immunoprecipitation study, we have observed that
the ASCL2 locus in human CRC cells contains two TCF4/b-cat-
enin-bound regulatory elements, indicating that ASCL2 is a direct
target of the Wnt pathway (Hatzis et al., 2008).
Like its fly counterparts, mammalian Ascl2 appears to control
lineage specification. In Ascl2-mutant mice, the spongiotropho-
blast layer is lost by embryonic day E10 at the expense of tropho-
blast giant cells (Guillemot et al., 1994; Hughes et al., 2004). The
current study demonstrates that Ascl2 is essential for the main-
tenance of Lgr5 stem cells in the adult intestinal epithelium and
that misexpression of Ascl2 in nonstem cells results in crypt
hyperplasia and crypt-like pockets on villi. In conclusion, we
have initiated a molecular characterization of the stem cell of
the intestinal epithelium by gene expression profiling of essen-
tially pure Lgr5 stem cells. The current study of Ascl2 demon-
strates that, with the available genetic tools, the intestinal epithe-
lium constitutes a prime model to unveil molecular mechanisms
underlying the biology of stem cells.
EXPERIMENTAL PROCEDURES
Isolation of GFP-Positive Epithelial Cells
Freshly isolated small intestines were incised along their length and villi were
removed. The intestinal tissue was washed in PBS/EDTA (5 mM) for 5 min, and
subsequently incubated in fresh PBS/EDTA for 30 min at 4C. Vigorous shaking
yielded free crypts which were incubated in PBS supplemented with Trypsine
(10 mg/ml) and DNase (0.8 u/ml) for 30 min at 37C. After incubation, cells were
spun down, resuspended in SMEM (Invitrogen) and filtered through a 40 mm
mesh. GFP-expressing cells were isolated using a MoFlo cell sorter (DAKO).
Microarray Analysis
RNA was isolated from sorted GFPhi and GFPlo cell fractions of intestines from
Lgr5-EGFP-ires-CreERT2 mice. For the analysis of Ascl2 target genes, RNA
was isolated from intestinal epithelial cells of Ah-Cre/Ascl2floxed/floxed animals
and Ah-Cre/Ascl2floxed/wt control animals 3 and 5 days post Cre induction.
500 ng of total RNA was labeled using low RNA Input Linear Amp kit (Agilent
Technologies, Pato Alto, CA, USA). Labeling, hybridization, and washing
protocols were done according to Agilent guidelines. Detailed information is
available in Supplemental Experimental Procedures.
Mice
The villin-Ascl2 transgenic expression construct was generated by cloning the
mouse Ascl2 coding sequence at the initiation codon of the 9-kb regulatory
region of the mouse villin gene (Pinto et al., 1999). An SV40 termination and
polyadenylation cassette was added downstream (Figure 2B, insert). Condi-
tional Ascl2 mice were generated through homologous recombination in
embryonic stem cells as depicted in Figure S3A. More detailed information
is available in Supplemental Experimental Procedures. The transgenic Ah-
Cre line (Ireland et al., 2004) was crossed with conditional Ascl2 mice toCell 136, 903–912, March 6, 2009 ª2009 Elsevier Inc. 909
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Figure 7. Ascl2 Target Genes
(A) Venn diagram showing the overlap between the
stem cell signature (Table S1) and the Ascl2 target
genes. Ascl2 target genes have been identified
through comparative gene profiling of RNA
samples from isolated intestinal epithelium of
Ah-Cre/Ascl2floxed/floxed animals and Ah-Cre/
Ascl2floxed/wt control animals at day 3 and 5 days
PI. For the comparison of the stem cell genes
and the Ascl2 target genes only those genes
expressed in both lists were compared. The iden-
tity of the overlapping genes is given in Table S2.
(B) Association of ASCL2 with the proximal
promoters and enhancers of the indicated Ascl2
target genes. ASCL2 binding to indicated regions
is expressed as relative enrichment of the respec-
tive qPCR product over the qPCR product of the
nonbound exon2 of the myoglobin gene. Experi-
ments have been performed at least three times.
A representative experiment is shown.
(C) Transcriptional activity of SOX9 enhancer in
integrated inducible ASCL2 RNAi LS174T cell
line. Luciferase reporter containing the SOX9
enhancer was transiently transfected in the
LS174T ASCL2 RNAi cell line. A CMV-Renilla
reporter was cotransfected as a normalizing
control. Cells were induced for 24 hr with doxycy-
cline to induce the sh-RNA against ASCL2. Control and ASCL2 RNAi values are normalized over the empty pGL4.10 TATA construct. Experiments have been
performed at least three times. A representative experiment is shown. Values are the average of normalized triplicates and error bars represent standard devi-
ations of these triplicates.
(D) Transcriptional activity of SOX9 enhancer in stably integrated inducible ASCL2 HCT116 cell line. Luciferase reporter containing the SOX9 enhancer was tran-
siently transfected in inducible ASCL2 HCT116 CRC cell line. A CMV-Renialla reporter was cotransfected as a normalizing control. Cells were induced for 24 hr
with doxycycline to induce ASCL2 expression. Control and ASCL2 induction values are normalized over the empty pGL4.10 TATA construct. Experiments have
been performed at least three times. A representative experiment is shown. Values are the average of normalized triplicates and error bars represent standard
deviations of these triplicates.generate Ah-Cre/Ascl2floxed/floxed mice. The Cre enzyme was induced in mice
6-12 weeks old of age by intraperitoneal injections at day 0 of 200 ml b-naptho-
flavone (10 mg ml-1; Sigma Aldrich) dissolved in corn oil.
Isolation of Intestinal Cells for Southern and Northern Blot Analysis
Intestines were cut into small pieces and washed in ice-cold PBS (Mg2+/Ca2+).
The intestinal pieces were incubated in 30 mM EDTA in PBS at 37 degrees fol-
lowed by shaking. The released epithelium was then collected to prepare DNA
or RNA by standard procedures.
Histology, Immunohistochemistry, and In Situ Hybridization
Tissues were fixed in 10% formalin, paraffin embedded, and sectioned. Anti-
bodies: anti-Ki67 (1:100; Novacastra), rabbit anti-c-Myc (1:500; Upstate
Biotechnology), mouse anti-Ascl2 (1:5; Supplemental Experimental Proce-
dures), rabbit anti-Sox9 (1:600, Chemicon), rabbit anti-Caspase-3 (1:400;
Cell signaling), rabbit anti-GFP (1:6000, gift fromE.Cuppen). Peroxidaseconju-
gated secondary antibodies used were Mouse or Rabbit EnVision+ (DAKO).
Mouse ESTs were from RZPD. Protocols for in vitro transcription and in situ
hybridizations are described elsewhere (Gregorieff et al., 2005). b-galactosi-
dase (LacZ) staining was done as described previously (Barker et al., 2007).
Electron Microscopy Analysis
Tissues were fixed in 2.5% glutaraldehyde + 2.0% paraformaldehyde in caco-
dylate-buffer, postfixed in 1% OsO4, stained en bloced with uranylacetate,
and embedded in Epon resin. The samples were examined with a Phillips
CM10 microscope (Eindhoven, The Netherlands).
Generation of Transfected Cell Lines
T-Rex system (Invitrogen) was used to generate a clonal ASCL2- inducible
HCT116 cell line as described previously (van de Wetering et al., 2002).910 Cell 136, 903–912, March 6, 2009 ª2009 Elsevier Inc.LS174T cells were used to generate a clonal stable, inducible ASCL2 shRNA
cell line using the pTER system as described previously (van de Wetering
et al., 2003). Oligonucleotides: Table S3.
ChIP, qPCR, and Reporter Assays
ChIP, qPCR, and Reporter array protocols were performed as described previ-
ously (Hatzis et al., 2008) with small modifications. Detailed information is
available in Supplemental Experimental Procedures.
ACCESSION NUMBERS
Microarray data have been deposited in the Gene Expression Omnibus Data-
base with the accession number GSE14201.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, three
tables, five figures, and Supplemental References and can be found with
this article online at http://www.cell.com/supplemental/S0092-8674(09)
00079-8.
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